.. Amarex joins OmniComm Systems’ CRO Preferred Program OmniComm Systems, Inc. , a head in integrated digital data capture solutions for scientific trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Corporation to provide eClinical solutions for the next Phase III trial investigating the usage of a medical gadget for wound healing. The analysis will be conducted at over 30 sites and can recruit up to 300 patients during the period of 2 yrs. Amarex also joins OmniComm’s CRO Preferred System, that may allow them to offer OmniComm’s flexible, robust electronic data capture remedy, TrialMaster, to their clients. Amarex also advantages from the CRO Program’s unique advantages that include set pricing with no hidden fees, complete product sales and marketing support, and devoted hosting providers in OmniComm’s top notch hosting service.The Kaiser Daily Wellness Policy Report is published for Kaisernetwork.org, a free assistance of The Henry J. Kaiser Family Foundation. Copyright 2008 Advisory Table Kaiser and Company Family Foundation. All rights reserved.. Behavioral stress accelerates prostate cancer development in mice Prostate cancer individuals have increased degrees of stress and anxiety; however, several recent research have found that guys who take medicines that interfere with the strain hormone adrenaline possess a lesser incidence of prostate cancers. In this problem of the Journal of Clinical Investigation George Kulik and co-workers at Wake Forest University examined the partnership between stress and cancers progression in a mouse style of prostate cancers.